Global and North America Rare Disease Drug Market Status and Future Forecast 2013-2023

May 2018 | 95 pages | ID: GD123F75C60EN
99Strategy

Abstracts

SUMMARY

Key Content of Chapters (Including and can be customized)

Part 1:
Market Overview, Development, and Segment by Type, Application & Region
Part 2:
Global Market by company, Type, Application & Region
Part 3:
North America Market by company, Type, Application & Region
Part 4-6:
Key Regions of North America Market by Type, Application
Part 7:
Company information, Sales, Cost, Margin etc.
Part 8:
Conclusion

Market Segment as follows:

By Region

• Global (North America, Europe, Asia etc.)
• North America (United States, Canada, Mexico)

Key Companies

• Novartis AG
• Bristol-Myers Squibb Company
• Celgene Corporation
• F. Hoffmann-La Roche Ltd.
• Pfizer, Inc.
• Sanofi S.A.
• Alexion Pharmaceuticals, Inc.
• Eli Lilly and Company
• Novo Nordisk A/S
• AstraZeneca
• Eisai Co., Ltd.
• Daiichi Sankyo Company Limited
• Bayer AG
• GlaxoSmithKline
• Merck & Co., Inc.
• Johnson & Johnson
• Biogen, Inc.
• Shire
• Amgen, Inc.
• Deciphera
• Atara Biotherapeutics
• ProQR

Market by Type

• >1?
• 0.65??1?
• <0.1?

Market by Application

• Hospital Pharmacies
• Speciality Pharmacies
• Retail pharmacies
• Others

Contents

PART 1 MARKET OVERVIEW

1.1 Market Definition
1.2 Market Development
1.3 By Type
1.4 By Application
1.5 By Region

PART 2 GLOBAL MARKET STATUS AND FUTURE FORECAST

2.1 Global Market by Region
2.2 Global Market by Company
2.3 Global Market by Type
2.4 Global Market by Application
2.5 Global Market by Forecast

PART 3 NORTH AMERICA MARKET STATUS AND FUTURE FORECAST

3.1 North America Market by Region
3.2 North America Market by Company
3.3 North America Market by Type
3.4 North America Market by Application
3.5 North America Market by Forecast

PART 4 UNITED STATES MARKET STATUS AND FUTURE FORECAST

4.1 United States Market by Type
4.2 United States Market by Application
4.3 United States Market by Forecast

PART 5 CANADA MARKET STATUS AND FUTURE FORECAST

5.1 Canada Market by Type
5.2 Canada Market by Application
5.3 Canada Market by Forecast

PART 6 MEXICO MARKET STATUS AND FUTURE FORECAST

6.1 Mexico Market by Type
6.2 Mexico Market by Application
6.3 Mexico Market by Forecast

PART 7 KEY COMPANIES

7.1 Novartis AG
7.2 Bristol-Myers Squibb Company
7.3 Celgene Corporation
7.4 F. Hoffmann-La Roche Ltd.
7.5 Pfizer, Inc.
7.6 Sanofi S.A.
7.7 Alexion Pharmaceuticals, Inc.
7.8 Eli Lilly and Company
7.9 Novo Nordisk A/S
7.10 AstraZeneca
7.11 Eisai Co., Ltd.
7.12 Daiichi Sankyo Company Limited
7.13 Bayer AG
7.14 GlaxoSmithKline
7.15 Merck & Co., Inc.
7.16 Johnson & Johnson
7.17 Biogen, Inc.
7.18 Shire
7.19 Amgen, Inc.
7.20 Deciphera
7.21 Atara Biotherapeutics
7.22 ProQR

PART 8 CONCLUSION

List Of Tables

LIST OF TABLES

Table Type of Rare Disease Drug
Table Application of Rare Disease Drug
Table Global Rare Disease Drug Market by Region, 2013-2017 (Million USD)
Table Global Rare Disease Drug Market by Region, 2013-2017 (Volume)
Table Price List by Region, 2013-2017
Table Global Rare Disease Drug Market by Company, 2013-2017 (Million USD)
Table Global Rare Disease Drug Market by Company, 2013-2017 (Volume)
Table Price List by Company, 2013-2017
Table Global Rare Disease Drug Market by Type, 2013-2017 (Million USD)
Table Global Rare Disease Drug Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Global Rare Disease Drug Market by Application, 2013-2017 (Million USD)
Table Global Rare Disease Drug Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table North America Rare Disease Drug Market by Region, 2013-2017 (Million USD)
Table North America Rare Disease Drug Market by Region, 2013-2017 (Volume)
Table Price List by Region, 2013-2017
Table North America Rare Disease Drug Market by Company, 2013-2017 (Million USD)
Table North America Rare Disease Drug Market by Company, 2013-2017 (Volume)
Table Price List by Company, 2013-2017
Table North America Rare Disease Drug Market by Type, 2013-2017 (Million USD)
Table North America Rare Disease Drug Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table North America Rare Disease Drug Market by Application, 2013-2017 (Million USD)
Table North America Rare Disease Drug Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table United States Rare Disease Drug Market by Type, 2013-2017 (Million USD)
Table United States Rare Disease Drug Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table United States Rare Disease Drug Market by Application, 2013-2017 (Million USD)
Table United States Rare Disease Drug Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Canada Rare Disease Drug Market by Type, 2013-2017 (Million USD)
Table Canada Rare Disease Drug Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Canada Rare Disease Drug Market by Application, 2013-2017 (Million USD)
Table Canada Rare Disease Drug Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Mexico Rare Disease Drug Market by Type, 2013-2017 (Million USD)
Table Mexico Rare Disease Drug Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Mexico Rare Disease Drug Market by Application, 2013-2017 (Million USD)
Table Mexico Rare Disease Drug Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Novartis AG Information
Table Rare Disease Drug Sales, Cost, Margin of Novartis AG
Table Bristol-Myers Squibb Company Information
Table Rare Disease Drug Sales, Cost, Margin of Bristol-Myers Squibb Company
Table Celgene Corporation Information
Table Rare Disease Drug Sales, Cost, Margin of Celgene Corporation
Table F. Hoffmann-La Roche Ltd. Information
Table Rare Disease Drug Sales, Cost, Margin of F. Hoffmann-La Roche Ltd.
Table Pfizer, Inc. Information
Table Rare Disease Drug Sales, Cost, Margin of Pfizer, Inc.
Table Sanofi S.A. Information
Table Rare Disease Drug Sales, Cost, Margin of Sanofi S.A.
Table Alexion Pharmaceuticals, Inc. Information
Table Rare Disease Drug Sales, Cost, Margin of Alexion Pharmaceuticals, Inc.
Table Eli Lilly and Company Information
Table Rare Disease Drug Sales, Cost, Margin of Eli Lilly and Company
Table Novo Nordisk A/S Information
Table Rare Disease Drug Sales, Cost, Margin of Novo Nordisk A/S
Table AstraZeneca Information
Table Rare Disease Drug Sales, Cost, Margin of AstraZeneca
Table Eisai Co., Ltd. Information
Table Rare Disease Drug Sales, Cost, Margin of Eisai Co., Ltd.
Table Daiichi Sankyo Company Limited Information
Table Rare Disease Drug Sales, Cost, Margin of Daiichi Sankyo Company Limited
Table Bayer AG Information
Table Rare Disease Drug Sales, Cost, Margin of Bayer AG
Table GlaxoSmithKline Information
Table Rare Disease Drug Sales, Cost, Margin of GlaxoSmithKline
Table Merck & Co., Inc. Information
Table Rare Disease Drug Sales, Cost, Margin of Merck & Co., Inc.
Table Johnson & Johnson Information
Table Rare Disease Drug Sales, Cost, Margin of Johnson & Johnson
Table Biogen, Inc. Information
Table Rare Disease Drug Sales, Cost, Margin of Biogen, Inc.
Table Shire Information
Table Rare Disease Drug Sales, Cost, Margin of Shire
Table Amgen, Inc. Information
Table Rare Disease Drug Sales, Cost, Margin of Amgen, Inc.
Table Deciphera Information
Table Rare Disease Drug Sales, Cost, Margin of Deciphera
Table Atara Biotherapeutics Information
Table Rare Disease Drug Sales, Cost, Margin of Atara Biotherapeutics
Table ProQR Information
Table Rare Disease Drug Sales, Cost, Margin of ProQR

List Of Figures

LIST OF FIGURES

Figure Global Rare Disease Drug Market Share by Type in 2018
Figure Global Rare Disease Drug Market Share by Application in 2018
Figure Global Rare Disease Drug Market Share by Region in 2018
Figure North America Rare Disease Drug Market Share by Region in 2018
Figure Global Rare Disease Drug Market Share by Region in 2017 (Million USD)
Figure Global Rare Disease Drug Market Share by Region in 2017 (Volume)
Figure Global Rare Disease Drug Market Share by Company in 2017 (Million USD)
Figure Global Rare Disease Drug Market Share by Company in 2017 (Volume)
Figure Global Rare Disease Drug Market Share by Type in 2017 (Million USD)
Figure Global Rare Disease Drug Market Share by Type in 2017 (Volume)
Figure Global Rare Disease Drug Market Share by Application in 2017 (Million USD)
Figure Global Rare Disease Drug Market Share by Application in 2017 (Volume)
Figure Global Rare Disease Drug Market Forecast, 2018-2023 (Million USD)
Figure Global Rare Disease Drug Market Forecast, 2018-2023 (Volume)
Figure North America Rare Disease Drug Market Share by Region in 2017 (Million USD)
Figure North America Rare Disease Drug Market Share by Region in 2017 (Volume)
Figure North America Rare Disease Drug Market Share by Company in 2017 (Million USD)
Figure North America Rare Disease Drug Market Share by Company in 2017 (Volume)
Figure North America Rare Disease Drug Market Share by Type in 2017 (Million USD)
Figure North America Rare Disease Drug Market Share by Type in 2017 (Volume)
Figure North America Rare Disease Drug Market Share by Application in 2017 (Million USD)
Figure North America Rare Disease Drug Market Share by Application in 2017 (Volume)
Figure North America Rare Disease Drug Market Forecast, 2018-2023 (Million USD)
Figure North America Rare Disease Drug Market Forecast, 2018-2023 (Volume)
Figure United States Rare Disease Drug Market Share by Type in 2017 (Million USD)
Figure United States Rare Disease Drug Market Share by Type in 2017 (Volume)
Figure United States Rare Disease Drug Market Share by Application in 2017 (Million USD)
Figure United States Rare Disease Drug Market Share by Application in 2017 (Volume)
Figure United States Rare Disease Drug Market Forecast, 2018-2023 (Million USD)
Figure United States Rare Disease Drug Market Forecast, 2018-2023 (Volume)
Figure Canada Rare Disease Drug Market Share by Type in 2017 (Million USD)
Figure Canada Rare Disease Drug Market Share by Type in 2017 (Volume)
Figure Canada Rare Disease Drug Market Share by Application in 2017 (Million USD)
Figure Canada Rare Disease Drug Market Share by Application in 2017 (Volume)
Figure Canada Rare Disease Drug Market Forecast, 2018-2023 (Million USD)
Figure Canada Rare Disease Drug Market Forecast, 2018-2023 (Volume)
Figure Mexico Rare Disease Drug Market Share by Type in 2017 (Million USD)
Figure Mexico Rare Disease Drug Market Share by Type in 2017 (Volume)
Figure Mexico Rare Disease Drug Market Share by Application in 2017 (Million USD)
Figure Mexico Rare Disease Drug Market Share by Application in 2017 (Volume)
Figure Mexico Rare Disease Drug Market Forecast, 2018-2023 (Million USD)
Figure Mexico Rare Disease Drug Market Forecast, 2018-2023 (Volume)